Q. Ping Dou

Active 1991–2025

111
Papers
20,032
Citations
85
h-index
110
i10-index

Citations

Citations per year for Q. Ping Dou1987: 1 citations1989: 1 citations1991: 1 citations1992: 6 citations1993: 9 citations1994: 18 citations1995: 22 citations1996: 24 citations1997: 27 citations1998: 28 citations1999: 22 citations2000: 30 citations2001: 39 citations2002: 50 citations2003: 75 citations2004: 62 citations2005: 57 citations2006: 103 citations2007: 112 citations2008: 194 citations2009: 196 citations2010: 222 citations2011: 240 citations2012: 215 citations2013: 188 citations2014: 192 citations2015: 189 citations2016: 204 citations2017: 189 citations2018: 131 citations2019: 657 citations2020: 751 citations2021: 680 citations2022: 656 citations2023: 571 citations2024: 787 citations2025: 386 citations2026: 5 citations1988: no citations, so this year is not shown1990: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 1,797 citing papers, 22.9% of this breakdownUnited States: 1,597 citing papers, 20.3% of this breakdownIndia: 473 citing papers, 6% of this breakdownItaly: 316 citing papers, 4% of this breakdownGermany: 256 citing papers, 3.3% of this breakdownUnited Kingdom: 222 citing papers, 2.8% of this breakdownSouth Korea: 182 citing papers, 2.3% of this breakdownAustralia: 150 citing papers, 1.9% of this breakdownFrance: 148 citing papers, 1.9% of this breakdownSpain: 145 citing papers, 1.9% of this breakdownJapan: 145 citing papers, 1.8% of this breakdownCanada: 143 citing papers, 1.8% of this breakdown
0%22.9%Other 29.1%

Fields

  • Medicine45.2%
  • Biochemistry, Genetics and Molecular Biology34.1%
  • Nursing4.2%
  • Engineering3.2%
  • Chemistry2.9%
  • Materials Science2.3%
  • Other8.1%

Topics

  • Ubiquitin and proteasome pathways4.1%
  • Metal complexes synthesis and properties3.6%
  • Ferroptosis and cancer prognosis2.3%
  • Cancer-related Molecular Pathways2.2%
  • Tea Polyphenols and Effects2.2%
  • Autophagy in Disease and Therapy2.1%
  • Other83.5%

Coauthors

All papers

Open in search
  1. Connecting copper and cancer: from transition metal signalling to metalloplasia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature reviews. Cancer 2021 cited by 1,273

  2. Broad targeting of resistance to apoptosis in cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria Rosa Ciriolo, Katia Aquilano, Sophie Chen, Sulma I. Mohammed, W. Nicol Keith, Alan Bilsland, Dorota Halicka, Somaira Nowsheen, Asfar S. Azmi - Seminars in Cancer Biology 2015 cited by 846

  3. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2017 cited by 803

  4. Disulfiram, a Clinically Used Anti-Alcoholism Drug and Copper-Binding Agent, Induces Apoptotic Cell Death in Breast Cancer Cultures and Xenografts via Inhibition of the Proteasome Activity

    Authors: , , , - Cancer Research 2006 cited by 671

  5. Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives

    Authors: , , , , - Current Cancer Drug Targets 2011 cited by 802

  6. Novel Metals and Metal Complexes as Platforms for Cancer Therapy

    Authors: , , , , , , - Current Pharmaceutical Design 2010 cited by 538

  7. The role of ferroptosis in lung cancer

    Authors: , , , , , - Biomarker Research 2021 cited by 143

  8. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents

    Authors: , , , , , , , - Frontiers in Molecular Biosciences 2021 cited by 129

  9. Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator

    Authors: , , , - Seminars in Cancer Biology 2021 cited by 78

  10. Celastrol, a Triterpene Extracted from the Chinese “Thunder of God Vine,” Is a Potent Proteasome Inhibitor and Suppresses Human Prostate Cancer Growth in Nude Mice

    Authors: , , , , - Cancer Research 2006 cited by 585

  11. Designing a broad-spectrum integrative approach for cancer prevention and treatment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria Rosa Ciriolo, Helen M. Coley, Andrew Collins, Marisa Connell, Sarah Crawford, Colleen S. Curran, Charlotta Dabrosin, Giovanna Damia, Santanu Dasgupta, Ralph J. DeBerardinis, William K. Decker, Punita Dhawan, Anna Mae Diehl, Jin‐Tang Dong, Q. Ping Dou, Janice E. Drew, Eyad Elkord, Bassel F. El‐Rayes, Mark A. Feitelson, Dean W. Felsher, Lynnette R. Ferguson, Carmela Fimognari, Gary L. Firestone, Christian Frezza, Hiromasa Fujii, Mark M. Fuster, Daniele Generali, Alexandros G. Georgakilas, Frank Gieseler, Michael Gilbertson, Michelle Green, Brendan Grue, Gunjan Guha, Dorota Halicka, William G. Helferich, Petr Heneberg, Patricia Hentosh, Matthew D. Hirschey, Lorne J. Hofseth, Randall F. Holcombe, Kanya Honoki, Hsue-Yin Hsu, Gloria S. Huang, Lasse D. Jensen, Wen G. Jiang, Lee W. Jones, Phillip Karpowicz, W. Nicol Keith, Sid P. Kerkar, Gazala Khan, Mahin Khatami, Young Hee Ko, Ömer Küçük, Rob J. Kulathinal, Nagi B. Kumar, Byoung S. Kwon, Anne Le, Michael A. Lea, Ho‐Young Lee, Terry Lichtor, Liang Lin, Jason W. Locasale, Bal L. Lokeshwar, Valter D. Longo, Costas A. Lyssiotis, Karen L. MacKenzie, Meenakshi Malhotra, Maria Marino, Maria Luz Martínez‐Chantar, Ander Matheu and 80 more - Seminars in Cancer Biology 2015 cited by 298

  12. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance

    Authors: , , , , , , - Journal of Controlled Release 2009 cited by 272

  13. Citrus peel flavonoid nobiletin alleviates lipopolysaccharide-induced inflammation by activating IL-6/STAT3/FOXO3a-mediated autophagy

    Authors: , , , , , , - Food & Function 2020 cited by 88

  14. Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System

    Authors: , - Current Cancer Drug Targets 2014 cited by 276

  15. Targeting Ubiquitin–Proteasome System With Copper Complexes for Cancer Therapy

    Authors: , , , - Frontiers in Molecular Biosciences 2021 cited by 53

  16. Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents

    Authors: , , , - Recent Patents on Anti-Cancer Drug Discovery 2019 cited by 118

  17. Disulfiram Treatment Facilitates Phosphoinositide 3-Kinase Inhibition in Human Breast Cancer Cells In vitro and In vivo

    Authors: , , , , , , , - Cancer Research 2010 cited by 114

  18. Deubiquitination and stabilization of estrogen receptor α by ubiquitin-specific protease 7 promotes breast tumorigenesis

    Authors: , , , , , , , , , - Cancer Letters 2019 cited by 103

  19. A Novel Anticancer Gold(III) Dithiocarbamate Compound Inhibits the Activity of a Purified 20S Proteasome and 26S Proteasome in Human Breast Cancer Cell Cultures and Xenografts

    Authors: , , , , , - Cancer Research 2006 cited by 319

  20. Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Oncotarget 2014 cited by 171

  21. Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells

    Authors: , , , , , - Breast Cancer Research 2005 cited by 321

  22. Clioquinol, a Therapeutic Agent for Alzheimer's Disease, Has Proteasome-Inhibitory, Androgen Receptor–Suppressing, Apoptosis-Inducing, and Antitumor Activities in Human Prostate Cancer Cells and Xenografts

    Authors: , , , , , , , , - Cancer Research 2007 cited by 211

  23. Recent Advances in Antabuse (Disulfiram): The Importance of its Metal-binding Ability to its Anticancer Activity

    Authors: , , , , , - Current Medicinal Chemistry 2018 cited by 88

  24. Novel Schiff Base Copper Complexes of Quinoline-2 Carboxaldehyde as Proteasome Inhibitors in Human Prostate Cancer Cells

    Authors: , , , , , , - Journal of Medicinal Chemistry 2006 cited by 333